Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enzyme-inducing anticonvulsants improve tolerability of CCI-779 in patients with CNS tumors

Dec. 5, 2002

Improved tolerability of PZA in glioblastoma multiforme patients receiving anticonvulsants

Dec. 5, 2002

EMD-121794 reported to be well tolerated in patients with malignant gliomas

Dec. 5, 2002

Thalidomide plus temozolomide in malignant gliomas

Dec. 5, 2002

Good tolerability profile reported for tetracycline COL-3 in high-grade glioma

Dec. 5, 2002

Mercury Therapeutics licenses oncology target from Mass General

Dec. 4, 2002

Axcan receives approvable letter for Photofrin

Dec. 4, 2002

Enrollment completed in phase III trial of ABI-007

Dec. 4, 2002

Taxotere approved for first-line therapy in NSCLC

Dec. 4, 2002

Human Genome Sciences and Kirin announce license agreement

Dec. 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...